Group West Pharmaceutical Services, Inc.

Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Holding GmbH is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company is based in Eschweiler, Germany. 4040/40 delivers reliability and functionality that comes from a scientifically developed formulation paired with West's leadership in injectable drug containment and administration. West's Lined Seals can be used for single-dose or multi-dose applications and meet specifications to ensure strong device performance. Pharmaceutical, biotechnology, generic, and medical device companies trust our ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. The CEOs are George Lloyd Miller and Stephan Selke. The German company was founded in 1987.

Part of West Pharmaceutical Services, Inc., West Pharmaceutical Services Deutschland GmbH & Co. KG is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company is based in Eschweiler, Germany. Pharmaceutical, biotechnology, generic and medical device companies trust their ability to deliver consistent high-quality and technologically advanced containment and delivery solutions. The CEOs are George Lloyd Miller, Stephan Selke. West Pharmaceutical Services Deutschland offers products such as 4040/40, which delivers reliability and functionality that comes from a scientifically developed formulation paired with West's leadership in injectable drug containment and administration. Additionally, West's Lined Seals can be used for single-dose or multi-dose applications and meet specifications to ensure strong device performance. The German company was founded in 1997.

Part of West Pharmaceutical Services, Inc., Medimop Medical Projects Ltd. develops medical devices used as pharmaceutical connectors. The company is based in Raanana, Israel. Medimop Medical Projects was acquired by West Pharmaceutical Services, Inc. on July 05, 2005 for $41.80 million.